India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Yes Bank 12.86
Vedl 107.10 10.70
Tata Mot 131.60 2.61
Bharti A 425.90 7.21
State Ba 202.95
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Biocon Limited
Biocon Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:532523NSE:BIOCONBloomberg:BIOS@INReuters:BION.BO
Market Lot: 1Face Value: 5ISIN Demat: INE376G01013
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
Corporate News
29-Apr-2020       Biocon, Mylan jointly launch biosimilar Fulphila in Canada IRIS
12-Mar-2020       Biocon, Mylan win patent litigation asserted by Sanofi in US  IRIS
17-Dec-2018       Biocon's API manufacturing facility completes USFDA inspection IRIS
12-Nov-2018       Biocon's new generic facility in Bengaluru completes inspection IRIS
22-Oct-2018       Biocon, Mylan announce positive CHMP Opinion for Ogivri IRIS
24-Sep-2018       Biocon announces USFDA inspection of Bangalore unit IRIS
27-Jul-2018       Biocon quarterly profit surges 47%  IRIS
05-Jun-2018       Biocon-Mylan gets USFDA approval for generic Fulphila IRIS
27-Apr-2018       Biocon quarterly profit rises 2%  IRIS
24-Apr-2018       Biocon gains 3% as Pfizer's Herceptin biosimilar delayed further IRIS
12-Apr-2018       Mylan and Biocon seek to accelerate introduction of Adalimumab Biosimilar in EU IRIS
28-Mar-2018       Mylan, Biocon receive approval for Semglee biosimilar insulin glargine IRIS
21-Feb-2018       USFDA completes pre-approval inspection at Biocon Malyasia IRIS

 

 


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer